FibroGen (FGEN) Receives FDA Clearance to Proceed with FG-3019 Study in DMD
Go back to FibroGen (FGEN) Receives FDA Clearance to Proceed with FG-3019 Study in DMD| (NASDAQ: FGEN) | Delayed: 1.17 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.17 | 52 Week High | $31.90 | |||
| Open | $1.17 | 52 Week Low | $14.38 | |||
| Day High | $1.17 | P/E | N/A | |||
| Day Low | $1.17 | EPS | $0.00 | |||
| Volume | 574 | |||||
